Full-Time

Quality Training Manager

Posted on 8/26/2024

Vaxcyte

Vaxcyte

201-500 employees

Develops vaccines for bacterial infections

Biotechnology
Healthcare

Compensation Overview

$155k - $166kAnnually

+ Equity Component

Senior, Expert

San Carlos, CA, USA

Hybrid position requires in-office presence.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Communications
Requirements
  • Bachelor’s BA/BS degree or equivalent experience.
  • At least 5 years of experience in quality training, quality assurance, or quality management.
  • Experience with Veeva Vault Training or similar LMS platforms.
  • Strong knowledge and skills in GxP quality standards, methodologies, and tools.
  • Understanding of current regulatory expectations including 21CFR Part 11 requirements.
  • Excellent communication, presentation, and facilitation skills.
  • Ability to analyze and evaluate the quality training needs and outcomes.
  • Ability to work independently and collaboratively with cross-functional teams.
  • Proficient in Microsoft Office and SmartSheet.
  • Ability to meet deadlines and multi-task efficiently.
  • Strong attention to detail, organizational skills, ability to work in a faced paced environment.
Responsibilities
  • Ensure that the training compliance requirements are fulfilled and documented according to the applicable standards and regulations.
  • Work with departmental representatives to manage a role-based quality training program for new hires, existing employees, and contractors.
  • Assess the training needs and gaps of the organization and provide recommendations for improvement.
  • Manage Training Requirements, Curricula, Learner Roles, and Person records in the Veeva Vault Training LMS.
  • Monitor and evaluate the effectiveness and impact of the quality training program and provide feedback and reports including reporting on training compliance metrics and indicators.
  • Coordinate and collaborate with management to align the quality training programs with the organizational goals and objectives.
  • SME for Training during audits or inspections.
  • Stay updated on the latest trends and best practices in quality training and development.

Vaxcyte develops vaccines aimed at preventing bacterial infections, focusing on diseases like invasive pneumococcal disease, Group A Strep, periodontitis, and Shigella. Their lead product, VAX-24, is a pneumococcal conjugate vaccine that targets 24 strains of the Streptococcus pneumoniae bacteria and has received Breakthrough Therapy designation from the FDA. Vaxcyte utilizes advanced chemistry and a proprietary cell-free protein synthesis platform, XpressCF™, to create vaccines that can effectively address the complex defenses of bacteria while stimulating an immune response. Unlike traditional cell-based methods, their approach allows for the development of broad-spectrum vaccines. Vaxcyte's goal is to provide effective vaccines that can significantly reduce the impact of bacterial diseases on global health.

Company Stage

IPO

Total Funding

$273.3M

Headquarters

Foster City, California

Founded

2013

Growth & Insights
Headcount

6 month growth

2%

1 year growth

2%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • FDA Breakthrough Therapy designation for VAX-24 may accelerate its market entry.
  • Global pneumococcal vaccines market is projected to grow at a CAGR of 5.6% until 2030.
  • Recent $1.5 billion public offering strengthens Vaxcyte's financial position for future developments.

What critics are saying

  • Competition from mRNA technology developers like Moderna and BioNTech is intense.
  • Potential regulatory delays could impact Vaxcyte's clinical trial timelines.
  • Intellectual property disputes may arise over cell-free protein synthesis technology.

What makes Vaxcyte unique

  • Vaxcyte uses a proprietary cell-free protein synthesis platform, XpressCF™, for vaccine development.
  • Their lead product, VAX-24, targets 24 strains of Streptococcus pneumoniae bacteria.
  • Vaxcyte focuses on broad-spectrum vaccines for bacterial infections, unlike traditional methods.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Company Equity

Stock Options

Remote Work Options

INACTIVE